Genetic Foundations of Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder
Inflammatory demyelinating diseases of the central nervous system are characterized by immune-mediated damage to myelin, the lipid-rich insulating sheath that surrounds neuronal axons and enables rapid transmission of electrical impulses. Among these disorders, multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD) are clinically important because they can produce severe neurological disability while sharing several overlapping manifestations. Nevertheless, they are now recognized as distinct disease entities with different immunological, pathological, and genetic characteristics. The review by Ortiz and colleagues examines the genetic foundations of both diseases and emphasizes that neither MS nor NMOSD can be explained by a single causative gene. Instead, disease susceptibility emerges from interactions among numerous genetic variants, immune regulatory pathways, environmental exposures, and potentially epigenetic mechanisms. This multifactorial model is essential for understanding why genetically susceptible individuals may remain healthy while others develop disease following particular biological or environmental exposures.
Multiple Sclerosis: Genetics Interacting with the Environment
MS provides a particularly clear example of a complex disorder in which inherited susceptibility interacts with environmental influences. Epidemiological studies demonstrate that MS is more common in certain geographic regions and populations, while migration studies suggest that environmental exposure during childhood and adolescence may modify an individual's later risk. The review discusses sunlight exposure, vitamin D status, smoking, diet, intestinal microbiota, and viral infections—particularly Epstein–Barr virus—as potential contributors to susceptibility. Vitamin D is especially relevant because it has immunomodulatory effects, including inhibition of pro-inflammatory cytokine production and promotion of regulatory T-cell activity. The article's diagram on page 6 summarizes this multifactorial framework by linking environmental factors, viral exposure, microbiota, hormonal influences, and sex-related differences with MS development. Importantly, such factors do not act independently of genetics; rather, they may alter immune responses in individuals who already possess susceptibility-associated alleles, thereby helping to explain why MS does not follow a simple Mendelian inheritance pattern.
Familial Aggregation and the Genetic Architecture of Multiple Sclerosis
Evidence for a genetic contribution to MS is particularly strong in family and twin studies. The review reports that approximately 20% of individuals with MS have at least one affected relative, while first-degree relatives have a substantially greater risk than the general population. Concordance is also markedly higher among monozygotic twins than among dizygotic twins, demonstrating that greater genetic similarity increases disease susceptibility. However, most identical twins remain discordant for MS, meaning that one twin develops the disease while the other does not. This observation is scientifically important because it demonstrates that genetic predisposition is neither necessary nor sufficient by itself to determine disease occurrence. The diagram on page 7 illustrates the increased risk observed among twins and close relatives, while the familial aggregation model on page 12 further emphasizes the relationship between genetic relatedness and MS susceptibility. Current evidence therefore favors a polygenic architecture in which many common variants of relatively small effect, together with some less frequent variants and interactions among genes, contribute cumulatively to an individual's biological risk.
The HLA Region and Immune Regulation in Multiple Sclerosis
The strongest genetic association with MS occurs within the major histocompatibility complex, or human leukocyte antigen (HLA) region, on chromosome 6. HLA molecules regulate antigen presentation and therefore occupy a central position in adaptive immune responses, making their involvement biologically plausible in an autoimmune neurological disorder. Among the most important susceptibility alleles is **HLA-DRB1*15:01**, which the review identifies as a major genetic risk factor, with carriers having an approximately three- to fourfold greater risk of developing MS. The effect of HLA alleles is nevertheless highly context dependent: **HLA-DRB1*14** appears protective, whereas interactions between **HLA-DRB1*15** and other alleles can either increase or reduce disease risk. Such interactions illustrate the phenomenon of epistasis, in which the biological effect of one genetic variant depends on the presence of another. Beyond HLA, genome-wide association studies have identified numerous susceptibility loci involving genes such as **IL7RA, IL2RA, TYK2, CD6, IRF8, TNFRSF1A, PRKCE,** and **BCL2**, reinforcing the conclusion that disturbances in immune-cell signaling, cytokine regulation, antigen recognition, and inflammatory pathways are central to MS pathogenesis.
From Genetic Association to Biological Mechanism
A major challenge in contemporary neurogenetics is determining how statistically associated variants actually alter cellular function. The review highlights several examples in which functional studies have begun to bridge this gap. The MS-associated variant **rs6897932** in the **IL7R** gene influences alternative splicing and alters the balance between soluble and membrane-bound forms of the interleukin-7 receptor. Similarly, an **IL2RA** variant modifies the relative production of soluble and membrane-associated interleukin-2 receptor proteins. Another notable example is **rs1800693** in **TNFRSF1A**, which promotes production of a soluble form of the tumor necrosis factor receptor and may disrupt intracellular TNF signaling. These findings demonstrate that susceptibility variants frequently do not destroy a protein completely; instead, they subtly modify gene expression, RNA splicing, receptor abundance, or molecular interactions. Bioinformatic analyses described in the article further connect MS susceptibility genes with pathways including JAK–STAT signaling, T-cell receptor signaling, NF-κB-mediated inflammation, and broader immune regulatory networks. Consequently, the emerging model of MS genetics is one of altered immune-system regulation rather than a single defective molecular pathway.
Neuromyelitis Optica Spectrum Disorder Has a Distinct Genetic Profile
Although NMOSD can resemble MS clinically, particularly because both conditions can involve optic neuritis and spinal cord inflammation, its immunological and genetic characteristics differ substantially. A defining feature of many NMOSD cases is the presence of antibodies against aquaporin-4 (AQP4), a water-channel protein highly expressed in astrocytes; other patients may have antibodies against myelin oligodendrocyte glycoprotein or remain seronegative. Familial NMOSD is uncommon, accounting for only a small proportion of cases, but reported familial clustering supports a genetic contribution. The review identifies associations with several HLA alleles, including **HLA-DRB1*03:01, HLA-DRB1*16:02, HLA-DQB1*04:02,** and **HLA-DRB1*04:05**, although their frequencies and effects vary among ethnic populations. Non-HLA candidates include **AQP4, PD-1, IL-17, IL-7R, CD6, CD58, TNXB,** and **CNPY3**. Particularly noteworthy are variants within **TNXB** and **HLA-DQA1**, as well as polymorphisms affecting AQP4 expression. The article also emphasizes the importance of ancestry: Native American genetic ancestry appears to contribute significantly to NMOSD susceptibility in admixed Mexican populations, demonstrating that population genetics must be incorporated into studies of disease risk.
Toward Precision Neurology and a More Complete Model of Disease
Collectively, the evidence reviewed by Ortiz and colleagues demonstrates that MS and NMOSD should be understood as genetically complex immune-mediated disorders in which inherited susceptibility interacts continuously with environmental and epigenetic influences. Genome-wide association studies have transformed understanding of MS by identifying hundreds of susceptibility signals, yet a substantial proportion of heritability remains unexplained, indicating that rare variants, gene–gene interactions, gene–environment interactions, regulatory DNA, epigenetic modifications, and population-specific effects require further investigation. NMOSD genetics remains less comprehensively characterized, particularly because of its lower prevalence and biological heterogeneity among AQP4-positive, MOG-positive, and seronegative patients. Future research integrating whole-genome sequencing, transcriptomics, epigenomics, proteomics, immune-cell profiling, and detailed environmental exposure data may allow scientists to move from statistical association toward mechanistic understanding. Ultimately, such knowledge could improve differential diagnosis, enable individualized risk assessment, identify molecular biomarkers, and support precision therapies directed at the particular immunological pathways disrupted in each patient, bringing neurogenetics closer to a genuinely personalized approach to inflammatory demyelinating disease.
Disclaimer: This blog post is based on the provided research article and is intended for informational purposes only. It is not intended to provide medical advice. Please consult with a healthcare professional for any health concerns.
References:
Ortiz, G. G., Torres-Mendoza, B. M., Ramírez-Jirano, J., Marquez-Pedroza, J., Hernández-Cruz, J. J., Mireles-Ramirez, M. A., & Torres-Sánchez, E. D. (2023). Genetic basis of inflammatory demyelinating diseases of the central nervous system: multiple sclerosis and neuromyelitis optica spectrum. Genes, 14(7), 1319.
